Rosario Foti Selected Research

Rosario Foti Research Topics

Disease

12	Psoriatic Arthritis 10/2022 - 04/2016
11	Rheumatoid Arthritis 05/2022 - 01/2013
5	COVID-19 01/2022 - 11/2020
4	Arthritis (Polyarthritis) 01/2022 - 01/2014
3	Infections 05/2022 - 04/2016
3	Obesity 05/2022 - 01/2013
3	Ankylosing Spondylitis 01/2022 - 10/2017
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 06/2017
2	Necrosis 01/2020 - 07/2019
1	Thromboembolism 05/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022
1	Non-Radiographic Axial Spondyloarthritis 01/2022
1	digital ulcers 01/2022
1	Axial Spondyloarthritis 01/2022
1	Raynaud Disease (Raynaud's Disease) 01/2022
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021
1	Systemic Scleroderma (Systemic Sclerosis) 11/2021
1	Atrophy 06/2020
1	Inflammation (Inflammations) 06/2020
1	Body Weight (Weight, Body) 09/2019
1	Spondylarthropathies 07/2019
1	Neoplasms (Cancer) 01/2018
1	Uveitis 10/2017
1	Virus Diseases (Viral Diseases) 06/2017
1	Disease Progression 02/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2016
1	Latent Tuberculosis 04/2016
1	Anterior Uveitis 04/2016
1	Erdheim-Chester Disease 09/2015
1	Fever (Fevers) 10/2014
1	Anemia 01/2014
1	Lymphoma (Lymphomas) 07/2002
1	Hemorrhage 02/2002
1	Myocardial Infarction 02/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2002

Drug/Important Bio-Agent (IBA)

10	Biological ProductsIBA 05/2022 - 04/2016
6	Antirheumatic Agents (DMARD)IBA 05/2022 - 01/2013
5	Pharmaceutical PreparationsIBA 01/2022 - 04/2016
4	Adalimumab (Humira)FDA Link 02/2020 - 10/2014
3	secukinumabIBA 01/2022 - 10/2017
3	Etanercept (Enbrel)FDA Link 06/2020 - 01/2014
2	SteroidsIBA 01/2022 - 07/2019
2	Antinuclear AntibodiesIBA 01/2022 - 11/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	Rituximab (Mabthera)FDA Link 12/2021 - 12/2014
2	golimumab FDA Link 01/2021 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2019 - 01/2013
2	Tumor Necrosis Factor InhibitorsIBA 07/2019 - 01/2018
2	ametantrone (HAQ)IBA 01/2018 - 01/2014
2	Ustekinumab (CNTO 1275)FDA Link 10/2017 - 04/2016
2	Abatacept (Orencia)FDA Link 09/2017 - 04/2016
2	Methotrexate (Mexate)FDA LinkGeneric 12/2014 - 01/2013
1	apremilastIBA 10/2022
1	IgA receptor (protein B)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2021
1	VaccinesIBA 12/2021
1	GlucocorticoidsIBA 12/2021
1	ElementsIBA 11/2021
1	C-Reactive ProteinIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 12/2020
1	remdesivirIBA 12/2020
1	baricitinibIBA 12/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020
1	Oxygen (Dioxygen)IBA 12/2020
1	Interleukin-17 (Interleukin 17)IBA 11/2020
1	LipidsIBA 06/2020
1	Interleukin-12 (IL 12)IBA 09/2019
1	Immunologic Factors (Immunomodulators)IBA 09/2019
1	InterleukinsIBA 09/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2017
1	Iloprost (Ventavis)FDA Link 02/2017
1	Monoclonal AntibodiesIBA 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	tocilizumab (atlizumab)FDA Link 04/2016
1	Prednisone (Sone)FDA LinkGeneric 09/2015
1	Sirolimus (Rapamycin)FDA Link 09/2015
1	Anaplastic Lymphoma KinaseIBA 07/2002
1	Abciximab (ReoPro)FDA Link 02/2002
1	Heparin (Liquaemin)FDA LinkGeneric 02/2002

Therapy/Procedure

5	Therapeutics 05/2022 - 01/2013
3	Biological Therapy 05/2022 - 04/2016
1	Blood Transfusion (Blood Transfusions) 01/2014
1	Precision Medicine 01/2013
1	Stents 02/2002